| Literature DB >> 32214158 |
Shadi Ghiasi1, Alberto Greco2, Riccardo Barbieri3, Enzo Pasquale Scilingo2, Gaetano Valenza2.
Abstract
Standard functional assessment of autonomic nervous system (ANS) activity on cardiovascular control relies on spectral analysis of heart rate variability (HRV) series. However, difficulties in obtaining a reliable measure of sympathetic activity from HRV spectra limits the exploitation of sympatho-vagal metrics. On the other hand, measures of electrodermal activity (EDA) have been demonstrated to provide a reliable quantifier of sympathetic dynamics. In this study we propose novel indices of phasic autonomic regulation mechanisms by combining HRV and EDA correlates and thoroughly investigating their time-varying dynamics. HRV and EDA series were gathered from 26 healthy subjects during a cold-pressor test and emotional stimuli. Instantaneous linear and nonlinear (bispectral) estimates of vagal dynamics were obtained from HRV through inhomogeneous point-process models, and combined with a sensitive maker of sympathetic tone from EDA spectral power. A wavelet decomposition analysis was applied to estimate phasic components of the proposed sympatho-vagal indices. Results show significant statistical differences for the proposed indices between the cold-pressor elicitation and previous resting state. Furthermore, an accuracy of 73.08% was achieved for the automatic emotional valence recognition. The proposed nonlinear processing of phasic ANS markers brings novel insights on autonomic functioning that can be exploited in the field of affective computing and psychophysiology.Entities:
Mesh:
Year: 2020 PMID: 32214158 PMCID: PMC7096472 DOI: 10.1038/s41598-020-62225-2
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Timeline of the experimental protocol. The presentation order between CPT and affective elicitation, as well as the different kinds of emotional videos (positive, negative, and neutral) were randomized across subjects.
Figure 2Block scheme on the derivation of the proposed indices of sympathovagal balance from EDA sympathetic markers and HRV-related parasympathetic markers.
Figure 3Exemplary decomposition of instantaneous bispectral estimates and their combination with EDA metrics in tonic and phasic dynamics. Data are from one exemplary subject during resting and CPT phases. Blue lines indicate the original series, whereas red and yellow lines represent the low and high frequency components, respectively. The 10s grey area centred at 120s indicates the transition between rest and CPT phases.
List of features used in this study with their definitions and references of their extraction.
| Feature | Definition | Reference |
|---|---|---|
| First-moment statistic of the Inverse Gaussian distribution in point process framework (Mean of RR series) | [ | |
| Second-moment statistic of the Inverse Gaussian distribution in point process framework (Variance of RR series) | [ | |
| Root Mean Square of the Successive Differences (RMSSD) | [ | |
| Normalized mean number of times an hour in which the change in successive normal sinus (NN) intervals exceeds 50 ms | [ | |
| Integration of linear power spectrum estimate of RR series in the low frequency band (0.04–0.15 Hz) | [ | |
| Integration of linear power spectrum estimate of RR series in the high frequency band (0.14–0.45 Hz) | [ | |
| Ratio of LF and HF spectral powers | [ | |
| Double integration of the bispectrum of RR series in low and low frequency bands | [ | |
| Double integration of the bispectrum of RR series in low and high frequency bands | [ | |
| Double integration of the bispectrum of RR series in high and high frequency bands | [ | |
| Integration of time-frequency plane of EDA signal within the 0.045–0.25 Hz band | [ | |
| Ratio between | This paper | |
| The number of significant (above threshold) phasic driver peaks | [ | |
| The sum of SCR amplitudes with respect to significant peaks | [ | |
| The maximum value of phasic activity | [ | |
| Mean tonic activity computation | [ | |
| Ratio between | This paper | |
| Ratio between | This paper | |
| Ratio between | This paper | |
| Median value of phasic decomposition of | This paper | |
| Median value of phasic decomposition of | This paper | |
| Median value of phasic decomposition of | This paper | |
| Median value of phasic decomposition of the ratio between | This paper | |
| Median value of phasic decomposition of the ratio between | This paper | |
| Median value of phasic decomposition of the ratio between | This paper | |
| Area under the curve of phasic decomposition of | This paper | |
| Area under the curve of phasic decomposition of | This paper | |
| Area under the curve of phasic decomposition of | This paper | |
| Area under the curve of phasic decomposition of the ratio between | This paper | |
| Area under the curve of phasic decomposition of the ratio between | This paper | |
| Area under the curve of phasic decomposition of the ratio between | This paper | |
Figure 4Processing chain of valence recognition.
Figure 5Dynamic tracking of instantaneous estimates of HRV and EDA averaged among twenty six subjects. From the top, the instantaneous μ, , LF, HF, LF/HF, EDA, bispectral measures (HH, LH, LL) and the proposed sympathovagal indices (S, S, S) are depicted. The median and MAD of each estimate are expressed through the continuous black line and the gray area. The red line at 120s separates resting and CPT phase by considering 10s transition between these phase indicated by the gray rectangle.
Median and MAD values of each feature among all 26 subjects considering the last 30s of rest and the last 30s, 90s, and 180s of CPT. the pvalues are as a result of pairwise statistical comparison obtained by Wilcoxon Test.
| Feature | Rest(30s) | CPT(30s) | p-value | CPT(90s) | p-value | CPT(180s) | p-value |
|---|---|---|---|---|---|---|---|
| 868.69 ± 99.44 | 785.14 ± 96.63 | 785.97 ± 128.23 | 794.66 ± 122.07 | ||||
| 1028.56 ± 776.65 | 957.30 ± 576.27 | 0.50 | 659.79 ± 413.64 | 0.91 | 579.09 ± 362.41 | 0.81 | |
| 0.04 ± 0.02 | 0.02 ± 0.005 | 0.03 ± 0.02 | 0.03 ± 0.01 | ||||
| 23.28 ± 15.10 | 16.27 ± 12.48 | 14.41 ± 11.32 | 13 ± 10.10 | ||||
| 1038.49 ± 852.20 | 1165.42 ± 545.50 | 0.316 | 793.26 ± 401.85 | 0.14 | 984.45 ± 521.03 | 0.07 | |
| 756.11 ± 485.39 | 486.56 ± 257.47 | 402.88 ± 223.02 | 0.08 | 449.28 ± 188.34 | |||
| 2.01 ± 1.38 | 2.03 ± 1.4 | 0.58 | 2.27 ± 1.53 | 0.98 | 2.48 ± 1.63 | 0.79 | |
| (6.52 ± 4.39). 108 | (2.81 ± 2.17). 108 | (3.06 ± 1.86)108 | (2.96 ± 1.44). 108 | ||||
| (4.92 ± 3.02). 108 | (3.82 ± 2.65). 108 | (3.57 ± 2.09). 108 | 0.06 | (3.39 ± 1.86). 108 | |||
| (9.91 ± 7.49). 108 | (7.81 ± 6.34). 108 | 0.25 | (6.03 ± 5.08). 108 | 0.19 | (5.84 ± 4.03). 108 | 0.25 | |
| 2.67 ± 2.28 | 0.98 ± 0.86 | 0.64 ± 0.51 | 0.65 ± 0.52 | ||||
| 0.001 ± 0.001 | 0.003 ± 0.003 | 0.0026 ± 0.0021 | 0.002 ± 0.002 | ||||
| 0.88 ± 0.48 | 1.37 ± 0.85 | 1.49 ± 0.73 | 1.18 ± 0.53 | 0.36 | |||
| 87.04 ± 65.20 | 134.37 ± 120.94 | 97.49 ± 85.55 | 88.44 ± 77.31 | ||||
| 61.38 ± 47.12 | 86.08 ± 75.47 | 54.38 ± 47.350 | 61.09 ± 51.67 | ||||
| − 0.56 ± 0.88 | − 0.89 ± 0.77 | − 0.91 ± 0.68 | − 0.93 ± 0.73 | ||||
| (1.65 ± 1.32). 10−9 | (6.56 ± 6.27). 10−9 | (6.82 ± 5.63). 10−9 | (3.47 ± 3.20). 10−9 | ||||
| (1.62 ± 1.16). 10−9 | (5.98 ± 5.29). 10−9 | (5.40 ± 3.89). 10−9 | (3.44 ± 2.34). 10−9 | ||||
| (8.55 ± 7.57). 10−10 | (4.34 ± 3.65). 10−9 | (3.04 ± 2.29). 10−9 | (2.60 ± 1.89). 10−9 | 0.10 | |||
| (6.72 ± 6.72). 109 | (6.53 ± 6.53). 109 | 0.81 | (2.25 ± 2.25). 1010 | 0.10 | (3.51 ± 3.51). 1010 | 0.13 | |
| (4.39 ± 4.39). 109 | (4.86 ± 4.86). 109 | 0.24 | (1.39 ± 1.39). 1010 | 0.53 | (2.43 ± 2.43). 1010 | 0.79 | |
| (7.22 ± 7.22). 109 | (4.86 ± 4.86). 109 | 0.26 | (1.96 ± 1.96). 1010 | 0.52 | (3.72 ± 3.72). 1010 | 0.39 | |
| (7.59 ± 7.51). 10−9 | (2.41 ± 2.41). 10−8 | 0.87 | (1.08 ± 1.08). 10−7 | (1.84 ± 1.84). 10−7 | |||
| (6.85 ± 6.80). 10−9 | (1.78 ± 1.78). 10−8 | 0.33 | (1.04 ± 1.04). 10−8 | 0.10 | (1.55 ± 0.55). 10−7 | 0.95 | |
| (5.91 ± 5.88). 10−9 | (1.33 ± 1.33). 10−8 | 0.14 | (4.0009 ± 4.0009). 10−8 | 0.62 | (6.71 ± 6.71). 10−8 | 0.16 | |
| (6.72 ± 5.26). 109 | (6.54 ± 5.97). 109 | 0.34 | (2.25 ± 1.51). 1010 | (3.51 ± 2.22). 1010 | 0.27 | ||
| (4.38 ± 3.08). 109 | (4.86 ± 3.72). 109 | 0.45 | (1.39 ± 8.58). 109 | (2.43 ± 1.65). 1010 | 0.64 | ||
| (7.23 ± 5.97). 109 | (4.87 ± 4.04). 109 | 0.12 | (1.96 ± 1.63). 1010 | (3.72 ± 3.006). 1010 | 0.98 | ||
| (7.59 ± 6.88). 10−9 | (2.42 ± 2.34). 10−8 | (10.81 ± 9.88). 10−8 | (18.42 ± 15.53). 10−8 | ||||
| (6.84 ± 3.63). 10−9 | (1.78 ± 1.69). 10−8 | 0.06 | (10.43 ± 8.68). 10−8 | (15.53 ± 11.02). 10−8 | |||
| (5.91 ± 5.39). 10−9 | (1.33 ± 1.29). 10−8 | 0.22 | (4.01 ± 3.67). 10−8 | (6.71 ± 5.87). 10−8 | |||
Figure 6Valence recognition accuracy on validation set as a function of feature ranking selection implemented through the SVM-RFE-LOSO classifier.
Confusion matrix for valence recognition using the final feature set. Values are expressed as percentages.
| Feature set (Final) | Pleasant | Unpleasant |
|---|---|---|
| Pleasant | 69.23% | 30.77% |
| Unpleasant | 23.08% | 76.92% |
| Recognition accuracy: 73.08% | ||
Ranked feature list used for valence classification.
| Rank | Feature |
|---|---|
| 1 | |
| 2 | |
| 3 | |
| 4 | |
| 5 | |
| 6 | |
| 7 | LF/HF |
| 8 | |
| 9 | |
| 10 | |
| 11 | |
| 12 | |
| 13 | |
| 14 | |
| 15 | |
| 16 | |
| 17 | |
| 18 |
Confusion matrix for valence recognition using the feature set containing only HRV related indices.Values are expressed as percentages.
| Feature set ( | Pleasant | Unpleasant |
|---|---|---|
| Pleasant | 65.02% | 34.98% |
| Unpleasant | 38.16% | 61.84% |
| Recognition accuracy: 63.43% | ||
Confusion matrix for valence recognition using only standard measures of EDA. Values are expressed as percentages.
| Feature set ( | Pleasant | Unpleasant |
|---|---|---|
| Pleasant | 76.73% | 23.27% |
| Unpleasant | 39.77% | 60.23% |
| Recognition accuracy: 68.48% | ||